Back to the complete issue
Tuesday, 1 February 2022

Another daily covid case record + our first batch of Evusheld has arrived

Yet another record daily tally: The Health Ministry reported 2,223 new covid-19 infections yesterday, up from 2,210 the day before — a sixth consecutive record high as the omicron wave continues. Egypt has now disclosed a total of 425,911 confirmed cases of covid-19. The ministry also reported 31 new deaths, bringing the country’s total death toll to 22,635.

Remember: Cases aren’t expected to peak until at least the middle of this month, according to the head of Vacsera’s allergy center.

The vaccine tally: 26,138,418 people are now fully vaccinated against the virus, while some 11.3 mn people have received only their first shots and 620,004 people have received booster shots.

The government is aiming to have vaccinated 70% of the population by the start of 2H2022, Youm7 quoted health ministry spokesperson Hossam Abdel Ghaffar as saying. The country has so far inoculated 42% of people in targeted groups, he added. Around 60 mn people are eligible for vaccination.

We’ve received our first batch of Evusheld doses: 15k doses of AstraZeneca’s preventative antibody cocktail for the immunocompromised, Evusheld, arrived at Cairo International Airport on Saturday, the company announced in a press release (pdf). This makes Egypt the first country in Africa and the fourth worldwide to receive the med, according to the release. A total of 50k doses are expected to arrive this year, with more deliveries set to come in the next few weeks.

Where’s our Paxlovid? We were also expecting a shipment of Pfizer’s covid pill, Paxlovid, sometime in January, after we signed an agreement with the pharma giant to provide pills to treat some 20k people, but there’s been no word on those yet. Meanwhile, Merck’s Molnupiravir antiviral covid treatment was approved for emergency use in hospitals last week, paving the way for five local firms to begin supplying local hospitals with the medication.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.